Study of Ocular Penetration of Topically Administered Fluoroquinolones
NCT00924729
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Cataract Extraction
Interventions
DRUG:
Moxifloxacin 0.5% ophthalmic solution
DRUG:
Besifloxacin 0.6% ophthalmic suspension
Sponsor
Johns Hopkins University